Skip to main content
Cullinan Therapeutics, Inc. logo

Cullinan Therapeutics, Inc. — Investor Relations & Filings

Ticker · CGEM ISIN · US2300311063 US Manufacturing
Filings indexed 419 across all filing types
Latest filing 2026-04-28 Registration Form
Country US United States of America
Listing US CGEM

About Cullinan Therapeutics, Inc.

https://cullinantherapeutics.com/

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops therapies for autoimmune diseases and cancer. The company focuses on advancing a pipeline of potential first-in-class or best-in-class molecules designed to address high unmet medical needs. Its therapeutic approach leverages deep expertise in immune modulation to develop and advance differentiated treatments. Cullinan Therapeutics employs a strategy that combines scientific expertise with rigorous decision-making to accelerate the development of high-impact therapies for patients.

Recent filings

Filing Released Lang Actions
S-3ASR - Cullinan Therapeutics, Inc. (0001789972) (Filer)
Registration Form
2026-04-28 English
DEF 14A - Cullinan Therapeutics, Inc. (0001789972) (Filer)
Proxy Solicitation & Information Statement
2026-04-28 English
ARS - Cullinan Therapeutics, Inc. (0001789972) (Filer)
Annual Report
2026-04-28 English
SCHEDULE 13G/A - Cullinan Therapeutics, Inc. (0001789972) (Subject)
Major Shareholding Notification
2026-03-26 English
4 - CULLINAN THERAPEUTICS, INC. (0001789972) (Filer)
Director's Dealing
2026-02-26 English
4 - CULLINAN THERAPEUTICS, INC. (0001789972) (Filer)
Director's Dealing
2026-02-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.